Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Controlled Trial of AI-Assisted Reading Compared With Standard Radiology Interpretation for Malignant Hepatic Lesions on Contrast-Enhanced CT: Diagnostic, Clinical and Workflow Outcomes

NCT07768085 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT07768085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07768085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Controlled Trial of AI-Assisted Reading Compared With Standard Radiology Interpretation for Malignant Hepatic Lesions on Contrast-Enhanced CT: Diagnostic, Clinical and Workflow Outcomes
Lead sponsor
Shengjing Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 17, 2026
Completion date
December 31, 2027
Enrollment
40,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cyst, focal nodular hyperplasia, hepatic hemangioma, hepatic metastasis, hepatocellular carcinoma (hcc), intrahepatic cholangiocarcinoma (icc)